Peter Demuth
Chief Scientific Officer, Elicio Therapeutics, Inc.
Companies
- Elicio Therapeutics, Inc.Chief Scientific Officer Jun 7, 2023 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Elicio Therapeutics, Inc. ELTX21,543 shares2$33.6K at $1.56Feb 2, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 2, 2026Granted 20,800 shares of Elicio Therapeutics, Inc.2
- Dec 9, 2025Exercised options 362 shares at $4.41 of Elicio Therapeutics, Inc.3
- Dec 16, 2024Exercised options 381 shares at $4.41 of Elicio Therapeutics, Inc.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Dec 10, 2025
- 4SEC EDGARForm 4 filed Dec 18, 2024